Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice

Nature Medicine volume 2, pages 998–1004 (1996)Cite this article

Abstract

Chronic intestinal inflammation induced by 2,4,6,–trinitrobenzene sulfonic acid (TNBS) is characterized by a transmural granulomatous colitis that mimics some characteristics of human Crohn's disease. Here, we show that the transcription factor NF–κB p65 was strongly activated in TNBS–induced colitis and in colitis of interleukin–10–deficient mice. Local administration of p65 antisense phosphorothioate oligonucleotides abrogated clinical and histological signs of colitis and was more effective in treating TNBS–induced colitis than single or daily administration of glucocorticoids. The data provide direct evidence for the central importance of p65 in chronic intestinal inflammation and suggest a potential therapeutic utility of p65 antisense oligonucleotides as a novel molecular approach for the treatment of patients with Crohn's disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Podolsky, D.K. Inflammatory bowel disease. N. Engl. J. Med. 325, 928–935 (1995).

    Article  Google Scholar 

  2. Strober, W. & Neurath, M.F. Immunological diseases of the gastrointestinal tract. in Clinical Immunology (ed. Rich, R.R.) 1401–1428 (Mosby, St. Louis, 1995).

    Google Scholar 

  3. Strober, W. & Ehrhardt, R.O. Chronic intestinal inflammation: an unexpected outcome on cytokine or T cell receptor mutant mice. Cell 75, 203–205 (1993).

    Article  CAS  Google Scholar 

  4. Hammer, R.E. et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human [32m: An animal model of HLAB-27-associated human disorders. Cell 63, 1099–1112 (1990).

    Article  CAS  Google Scholar 

  5. Hermiston, M.L. & Gordon, J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270, 1203–1207 (1995).

    Article  CAS  Google Scholar 

  6. Hollander, G.A. et al. Severe colitis in mice with aberrant thymic selection. Immunity 3, 27–38 (1995).

    Article  CAS  Google Scholar 

  7. Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).

    Article  CAS  Google Scholar 

  8. Kiihn, R., Lohler, J., Rennick, D., Rajewsky, K. & Miiller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274 (1993).

    Article  Google Scholar 

  9. Rudolph, U. et al. Ulcerative colitis and adenocarcinoma of the colon in Gai2-deficient mice. Nature Genet. 10, 143–146 (1995).

    Article  CAS  Google Scholar 

  10. Mombaerts, P. et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 275–282 (1993).

    Article  CAS  Google Scholar 

  11. Powrie, F. F. etal. Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBM CD4+ T cells. Immunity 1, 553–562 (1994).

    Article  CAS  Google Scholar 

  12. Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E. & Strober, W. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1280–1289 (1995).

    Article  Google Scholar 

  13. Stuber, E., Strober, W. & Neurath, M.F. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of Thl-T cells through the inhibition of IL-12 secretion. J. Exp. Med. 183, 693–698 (1996).

    Article  CAS  Google Scholar 

  14. Cross, S.L. et al. Functionally distinct NF-κB binding sites in the Ig kappa and IL-2 receptor alpha chain genes. Science 244, 466–469 (1989).

    Article  CAS  Google Scholar 

  15. Finco, T.S. & Baldwin, A.S. Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis. Immunity 3, 263–272 (1995).

    Article  CAS  Google Scholar 

  16. Lenardo, M.J. & Baltimore, D. NF-κB: A pleiotropic activator of inducible and tissue specific gene control. Cell 58, 227–237 (1989).

    Article  CAS  Google Scholar 

  17. Baeuerle, P.A. & Henkel, T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141–179 (1994).

    Article  CAS  Google Scholar 

  18. Sha, W. et al. Targeted disruption of the p50 subunit of NF-κB leads to multifo-cal defects in immune responses. Cell 80, 321–330 (1995).

    Article  CAS  Google Scholar 

  19. Weih, F. et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κBJRel family. Cell 80, 331–340 (1995).

    Article  CAS  Google Scholar 

  20. Kontgen, F. et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965–1977 (1995).

    Article  CAS  Google Scholar 

  21. Burkly, L. et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531–536 (1995).

    Article  CAS  Google Scholar 

  22. Shakhov, A.N. et al. KB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J. Exp. Med. 171, 35–47 (1990).

    Article  CAS  Google Scholar 

  23. Libermann, T.A. & Baltimore, D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10, 2327–2334 (1990).

    Article  CAS  Google Scholar 

  24. Higgins, K.A. et al. Antisense inhibition of the p65 subunit of NF-κB blocks tu-morigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90, 9901–9905 (1993).

    Article  CAS  Google Scholar 

  25. Kitajima, I. et al. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258, 1792–1795 (1992).

    Article  CAS  Google Scholar 

  26. Krieg, A.M. CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374, 546–549 (1995).

    Article  CAS  Google Scholar 

  27. Loke, S.L. et al. Delivery of c-myc antisense phosphorothioate oligodeoxynu-cleotides to hematapoietic cells in culture by liposome fusion: Specific reduction in c-Myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr. Top. Microbiol. Immunol. 141, 282–288 (1988).

    CAS  PubMed  Google Scholar 

  28. Venturelli, D., Travali, S. & Calabretta, B. Inhibition of T-cell proliferation of a Myb antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. Proc. Natl. Acad. Sci. USA 87, 5963–5967 (1990).

    Article  CAS  Google Scholar 

  29. Voltieri, M. et al. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cyclin activity and expression of DNA polymerase alpha. Blood 77, 1181–1190 (1991).

    Google Scholar 

  30. Holt, J.T. et al. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83, 4794–4798 (1986).

    Article  CAS  Google Scholar 

  31. Nishikura, K. & Murray, J.M. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol. Cell. Biol. 7, 639–648 (1987).

    Article  CAS  Google Scholar 

  32. Wakatsuki, Y., Neurath, M.F., Max, E.E. & Strober, W. The B cell specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 179, 1099–1108 (1994).

    Article  CAS  Google Scholar 

  33. Gura, T. Antisense has growing pains. Science 270, 575–577 (1995).

    Article  CAS  Google Scholar 

  34. Wagner, R.W. et al. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260, 1510–1514 (1993).

    Article  CAS  Google Scholar 

  35. Wagner, R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333–335 (1994).

    Article  CAS  Google Scholar 

  36. Nesterova, M. & Cho-Chung, Y.S. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nature Med. 1, 528–533 (1995).

    Article  CAS  Google Scholar 

  37. Holt, J.T. A ‘senseless’ immune response to DNA. Nature Med. 1, 407–408 (1995).

    Article  CAS  Google Scholar 

  38. Wringhton, C.J. et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of IKBCX, an inhibitor of the transcription factor NF-κB. J. Exp. Med. 183, 1013–1022 (1996).

    Article  Google Scholar 

  39. van Dullemen, H.M. et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109, 129–135 (1995).

    Article  CAS  Google Scholar 

  40. Sartor, R.B. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can. J. Gastroenterol. 4, 271–277 (1990).

    Article  Google Scholar 

  41. Duchmann, R., Schmitt, E., Knolle, P., Meyer zum Büelde, K.-H. & Neurath, M.F. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26, 934–938 (1996).

    Article  CAS  Google Scholar 

  42. Wang, P., Wu, P., Siegel, M.L., Egan, R.W. & Billah, M.M. Interleukin (IL)-10 inhibits nuclear factor B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270, 9558–9563 (1995).

    Article  CAS  Google Scholar 

  43. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K. & Baldwin, A.S. Role of transcriptional activation of IKBOC in mediation of immunosuppression by glucocor-ticoids. Science 270, 283–286 (1995).

    Article  CAS  Google Scholar 

  44. Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A. & Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IKBCC synthesis. Science 270, 286–290 (1995).

    Article  CAS  Google Scholar 

  45. Neurath, M.F., Max, E.E. & Strober, W. Pax5 (BSAP) regulates the murine immunoglobulin 3'a enhancer by affecting binding of NF-aP, a protein that controls heavy chain transcription. Proc. Natl. Acad. Sci. USA 92, 5336–5340 (1995).

    Article  CAS  Google Scholar 

  46. Demczuk, S., Harbers, M. & Vennstrom, B. Identification and analysis of all components of a gel retardation assay by combination with immunoblotting. Proc. Natl. Acad. Sci. USA 90, 2574–2578 (1993).

    Article  CAS  Google Scholar 

  47. Bull, D.M. & Bookman, M.A. Isolation and functional characterization of human intestinal mucosal mononuclear cells. J. Clin. Invest. 59, 966–974 (1977).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Immunology, I. Medical Clinic, University of Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany

    Markus F. Neurath & Karl-Hermann Meyer Zum Büschenfelde

  2. Center of Biotechnology, Karolinska Institute, 14157, Huddinge, Sweden

    Sven Pettersson

  3. Mucosal Immunity Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, 20892, USA

    Warren Strober

Authors
  1. Markus F. Neurath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sven Pettersson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl-Hermann Meyer Zum Büschenfelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Warren Strober
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neurath, M., Pettersson, S., Meyer Zum Büschenfelde, KH. et al. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice. Nat Med 2, 998–1004 (1996). https://doi.org/10.1038/nm0996-998

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0996-998

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing